Moderna, Inc.
MRNA
$59.81
$0.641.08%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -30.19% | -31.14% | -41.49% | -57.47% | -39.64% |
| Total Other Revenue | 35.83% | -6.04% | -1.57% | 3.42% | -19.46% |
| Total Revenue | -27.62% | -29.97% | -39.93% | -56.07% | -39.05% |
| Cost of Revenue | -29.90% | -34.76% | -33.41% | -28.50% | -35.89% |
| Gross Profit | 33.11% | 40.58% | 25.80% | -71.57% | 30.87% |
| SG&A Expenses | -10.15% | -11.96% | -13.29% | -17.94% | -26.13% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -26.56% | -31.09% | -30.12% | -26.74% | -34.42% |
| Operating Income | 25.57% | 32.05% | 22.08% | -28.59% | 29.39% |
| Income Before Tax | -4.82% | 7.87% | 23.26% | -34.00% | 32.02% |
| Income Tax Expenses | 252.38% | 214.29% | 217.39% | 71.32% | -102.74% |
| Earnings from Continuing Operations | -8.54% | 4.86% | 20.75% | -40.11% | 50.52% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.54% | 4.86% | 20.75% | -40.11% | 50.52% |
| EBIT | 25.57% | 32.05% | 22.08% | -28.59% | 29.39% |
| EBITDA | 28.38% | 35.00% | 23.88% | -37.81% | 25.37% |
| EPS Basic | -6.22% | 6.60% | 21.76% | -38.95% | 51.08% |
| Normalized Basic EPS | 26.12% | 33.71% | 23.18% | -36.35% | 31.77% |
| EPS Diluted | -6.12% | 6.67% | 21.82% | -38.25% | 51.13% |
| Normalized Diluted EPS | 26.14% | 33.73% | 23.20% | -36.10% | 31.79% |
| Average Basic Shares Outstanding | 2.01% | 1.62% | 1.30% | 1.11% | 1.05% |
| Average Diluted Shares Outstanding | 1.09% | 0.71% | 0.39% | -0.71% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |